Arcoma

7.26 SEK

Less than 1K followers

ARCOMA

First North Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

-0.55 %

-10.59 %

-19.33 %

-25.31 %

-32.47 %

-33.70 %

-6.92 %

-64.24 %

-45.49 %

Arcoma operates in the medical technology sector. The company is a developer and supplier of integrated digital X-ray systems. The company's products offer digital imaging technology combined with technically advanced mobile positioning systems. The products are sold through resellers and to a large proportion of OEM customers. Operations are found on a global level with sales primarily concentrated in Europe, Asia and North America. The head office is located in Växjö.

Market cap

103.88M SEK

Turnover

-

Revenue

156.81M

EBIT %

8.7 %

P/E

8.54

Dividend yield-%

-

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

12.2

2026

Annual report '25

All

Press releases

ShowingAll content types

Press release10/24/2025, 6:02 AM

DNB Carnegie Access: Arcoma: Europe muted, business mix supports margins – Q3 review

Press release10/13/2025, 4:52 PM

DNB Carnegie Access: Arcoma: Sequential improvements but US uncertainty – Q3 preview

Press release8/25/2025, 8:10 AM

DNB Carnegie Access: Arcoma: Intervju - Intervju efter Q2 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release8/22/2025, 6:00 AM

DNB Carnegie Access: Arcoma: US remains muted, easier comparisons in H2 – Q2 review

Press release7/8/2025, 1:02 PM

DNB Carnegie Access: Arcoma: Directed share issue, US to remain muted – Q2 preview

Regulatory press release6/24/2025, 5:15 PM

Arcoma AB successfully completes directed share issue of SEK 11.0 million (~ EUR 1 million) (MAR)

Press release4/29/2025, 2:39 PM

Carnegie Access: Arcoma: Solid gross margin, North America revenue declines – Q1 review

Press release2/17/2025, 2:20 PM

Carnegie Access: Arcoma: Intervju - Avslutar 2024 med starka marginaler (rapportintervju Q4)

Press release2/14/2025, 7:48 AM

Carnegie Access: Arcoma: Margins expand, but Europe remains under pressure – Q4 review

Regulatory press release6/12/2023, 11:00 AM

Arcoma signs distribution agreement with Canon Korea Inc.

Regulatory press release5/3/2023, 8:20 PM

Arcoma AB has received certification according to MDR (MAR)

Regulatory press release4/26/2023, 8:45 AM

Arcoma receives order of 10 systems to Thailand

Regulatory press release9/26/2022, 11:00 AM

Arcoma wins tender of 10 million SEK to Czech Republic (MAR)

Regulatory press release8/24/2022, 8:00 AM

Arcoma receives order of 8 systems to Thailand (MAR)

Regulatory press release7/7/2022, 11:00 AM

Arcoma Precision i5 approved for sales in Singapore

Regulatory press release6/27/2022, 11:00 AM

Arcoma wins important procurement in Finland. (MAR)

Regulatory press release11/18/2021, 3:20 PM

Valberedning utsedd inför årsstämma 2022 i Arcoma AB

Regulatory press release12/1/2020, 9:30 AM

Arcoma launches new X-ray system OMNERA 500A on the US market

Regulatory press release8/20/2020, 8:30 AM

Delårsrapport Q2 2020: Stabil försäljning trots Covid-19. Stark lönsamhetsförbättring under första halvåret.

Regulatory press release5/20/2020, 3:15 PM

Kommuniké från årsstämma i Arcoma AB (publ)

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.